- Home
- GNSS vs ETON Comparison
GNSS vs ETON Comparison
Compare GNSS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ETON
- Stock Information
- Founded
- GNSS 1992
- ETON 2017
- Country
- GNSS United States
- ETON United States
- Employees
- GNSS N/A
- ETON N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- ETON Health Care
- Exchange
- GNSS Nasdaq
- ETON Nasdaq
- Market Cap
- GNSS 169.5M
- ETON 199.5M
- IPO Year
- GNSS N/A
- ETON 2018
- Fundamental
- Price
- GNSS $3.75
- ETON $8.77
- Analyst Decision
- GNSS Strong Buy
- ETON Strong Buy
- Analyst Count
- GNSS 3
- ETON 3
- Target Price
- GNSS $5.08
- ETON $12.00
- AVG Volume (30 Days)
- GNSS 106.7K
- ETON 214.1K
- Earning Date
- GNSS 12-05-2024
- ETON 11-11-2024
- Dividend Yield
- GNSS N/A
- ETON N/A
- EPS Growth
- GNSS N/A
- ETON N/A
- EPS
- GNSS N/A
- ETON N/A
- Revenue
- GNSS $27,968,000.00
- ETON $31,381,000.00
- Revenue This Year
- GNSS N/A
- ETON $19.61
- Revenue Next Year
- GNSS $138.10
- ETON $35.39
- P/E Ratio
- GNSS N/A
- ETON N/A
- Revenue Growth
- GNSS N/A
- ETON 8.14
- 52 Week Low
- GNSS $1.51
- ETON $3.03
- 52 Week High
- GNSS $4.04
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- GNSS 60.29
- ETON 76.07
- Support Level
- GNSS $3.67
- ETON $7.58
- Resistance Level
- GNSS $3.94
- ETON $8.66
- Average True Range (ATR)
- GNSS 0.14
- ETON 0.42
- MACD
- GNSS -0.02
- ETON -0.07
- Stochastic Oscillator
- GNSS 77.78
- ETON 91.49
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.